Development of Regenerative Medicine for COPD

慢阻肺再生医学的发展

基本信息

  • 批准号:
    17590774
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

The bone marrow of the C57BL/6 mouse was reconstituted with GFP-transgenic, and the GFP-chimera mouse was made. The acute lung injury was developed by LPS in this chimera mouse, and the lung cells were analyzed by obtaining single cell suspension from the pulmonary tissue after 1, 2 or 6 months of LPS-instillation. FACS analyses were performed using several stem cell markers. As a result, the ratio of the GFP-positive cells in the alveolar walls gradually decreased at the stage of 6 months after acute lung injury. The endogenous stem cells of existing lungs in the chronic phase shows relations in the repair processes after the injury though the bone marrow-derived cell plays a major role at the acute repair period. Moreover, the GFP-positive cells did not exist in the population of lung endogenous stem cells, suggesting that the bone marrow cells were not a source of lung endogenous stem cells. These data suggested that not only the bone marrow-derived cell but also existing endogenous stem cells were important in repair processes of acute lung injury. Then, the role of the lung endogenous stem cells in the lung regeneration model from pulmonary emphysema was examined. The hepatocyte growth factor (HGF)-induced lung regeneration model in the elastase-induced emphysema was utilized for this study. As a result, increasing the number of cell groups with the stem cell markers such as CD34 in the pulmonary tissue was observed, and these cells were necessary for HGF-induced regeneration of the destroyed lungs. Moreover, it was clarified for HGF to increase the number of such lung endogenous stem cells, and to promote the differentiation of these stem cell groups into the mature lungs cells. These results are being in under revision in the Molecular Therapy.
将C57BL/6小鼠的骨髓进行GFP转基因重建,制成GFP嵌合体小鼠。该嵌合体小鼠因LPS而产生急性肺损伤,并通过在LPS滴注1、2或6个月后从肺组织中获取单细胞悬液来分析肺细胞。使用多种干细胞标记物进行 FACS 分析。结果,在急性肺损伤后6个月阶段,肺泡壁中GFP阳性细胞的比例逐渐下降。尽管骨髓源性细胞在急性修复期发挥主要作用,但慢性期现有肺部的内源性干细胞在损伤后的修复过程中显示出相关性。此外,肺内源性干细胞群中不存在GFP阳性细胞,表明骨髓细胞不是肺内源性干细胞的来源。这些数据表明,不仅骨髓来源的细胞,现有的内源性干细胞在急性肺损伤的修复过程中也很重要。然后,检查了肺内源性干细胞在肺气肿肺再生模型中的作用。本研究采用弹性蛋白酶诱导的肺气肿中肝细胞生长因子(HGF)诱导的肺再生模型。结果,观察到肺组织中带有干细胞标记物(例如 CD34)的细胞群数量增加,这些细胞是 HGF 诱导受损肺再生所必需的。此外,还阐明HGF可以增加这种肺内源性干细胞的数量,并促进这些干细胞群分化为成熟的肺细胞。这些结果正在分子疗法中进行修订。

项目成果

期刊论文数量(25)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Interleukin-1beta gene polymorphisms associated with COPD.
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    9.6
  • 作者:
    M. Asada;M. Yamaya;S. Ebihara;H. Yasuda;Naoki Tomita;H. Kubo;Hidetada Sasaki
  • 通讯作者:
    M. Asada;M. Yamaya;S. Ebihara;H. Yasuda;Naoki Tomita;H. Kubo;Hidetada Sasaki
Interaction of non-adherent suspended neutrophils to complement opsonized pathogens: a new assay using optical traps.
非粘附悬浮中性粒细胞与调理病原体的相互作用:一种使用光陷阱的新测定。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Suzuki T;et. al.
  • 通讯作者:
    et. al.
Comment on "Cutting Edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury
对“前沿:TLR4 缺乏导致对致命性氧化性肺损伤的易感性”的评论
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kubo H;et al.
  • 通讯作者:
    et al.
The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells
  • DOI:
    10.1016/j.ejphar.2004.12.042
  • 发表时间:
    2005-02-21
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Sasaki, T;Yamaya, M;Sasaki, H
  • 通讯作者:
    Sasaki, H
最新医学.肺損傷と修復の分子メカニズム.
肺损伤和修复的分子机制。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hirama N;Shibata Y;Otake K;Machiya J;Wada T;Inoue S;Abe S;Takabatake N;Sata M;Kubota I;久保裕司
  • 通讯作者:
    久保裕司
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUBO Hiroshi其他文献

The inhibitory effects of a new macrolide EM900 on rhinovirus infection in human airway epithelial cells
新型大环内酯类EM900对人呼吸道上皮细胞鼻病毒感染的抑制作用
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    LUSAMBA K. Nadine;YAMAYA Mutsuo;KUBO Hiroshi;OTA Chiharu;FUJINO Naoya;TANDO Yukiko;SATO Takeya; YANAGISAWA Teruyuki
  • 通讯作者:
    YANAGISAWA Teruyuki

KUBO Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUBO Hiroshi', 18)}}的其他基金

Differential space-time coding with large channel capacity in fast time-varying radio frequency environment
快时变射频环境下大信道容量差分空时编码
  • 批准号:
    25420393
  • 财政年份:
    2013
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of an anti-cancer effect of a novel marine natural compound, exiguolide.
新型海洋天然化合物 exigolide 的抗癌作用机制。
  • 批准号:
    23659427
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
International manufacturing management in photovoltaic module industry
光伏组件行业国际化制造管理
  • 批准号:
    22830072
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Human alveolar epithelial progenitor cells revealed pathophysiological mechanisms of refractory pulmonary diseases
人肺泡上皮祖细胞揭示难治性肺病的病理生理机制
  • 批准号:
    22390163
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study of film-type metamaterials with rejection characteristics for infrared rays
薄膜型超材料对红外线抑制特性的研究
  • 批准号:
    21560354
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Iung repair by lung endogenous stem cells
肺内源性干细胞修复肺
  • 批准号:
    19390222
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study of a meta-material whose permittivity or permeability can be changed from a negative value to a positive value
研究介电常数或磁导率可以从负值变为正值的超材料
  • 批准号:
    18560336
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis and application of the Kansei Mixture-Investigation for effect of relaxation-
感性合剂的分析与应用-放松效果研究-
  • 批准号:
    18200014
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
The role on bone marrow-derived cells in lung repair and regeneration.
骨髓源性细胞在肺修复和再生中的作用。
  • 批准号:
    15590792
  • 财政年份:
    2003
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An importance on bone marrow-derived cells on lung repair
骨髓来源细胞对肺修复的重要性
  • 批准号:
    13670589
  • 财政年份:
    2001
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Evaluating gamma-delta T cell therapy for osteosarcoma
评估骨肉瘤的 γ-δ T 细胞疗法
  • 批准号:
    MR/X033066/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Fellowship
Design and evolution of deimmunized protein superglues to enhance modular cell therapy
去免疫蛋白强力胶的设计和进化以增强模块化细胞疗法
  • 批准号:
    MR/Y011910/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
  • 批准号:
    10752046
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
Improving Chimeric Antigen Receptor (CAR) T-Cell Therapy Using Engineering Biology and Mechanobiological Approach
利用工程生物学和力学生物学方法改进嵌合抗原受体 (CAR) T 细胞疗法
  • 批准号:
    10074571
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant for R&D
Market Feasibility for a Engineering Biology Approach to Cell Therapy for Brain Cancer and Regenerative Medicine
脑癌和再生医学细胞治疗的工程生物学方法的市场可行性
  • 批准号:
    10074920
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant for R&D
A novel diagnostic tool leveraging AI for protein design and microfluidics for better cell therapy management
一种利用人工智能进行蛋白质设计和微流体技术以实现更好的细胞治疗管理的新型诊断工具
  • 批准号:
    10082156
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Collaborative R&D
Establishment of cell therapy using tissue stem cells derived from perifascial areolar tissue (PAT)
使用来自筋膜周围乳晕组织(PAT)的组织干细胞建立细胞疗法
  • 批准号:
    23K09089
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer
改造 T 细胞以克服抑制性受体信号,这些信号限制了过继性细胞疗法对卵巢癌的疗效
  • 批准号:
    10526155
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
BioSynth Trust: Developing understanding and confidence in flow cytometry benchmarking synthetic datasets to improve clinical and cell therapy diagnos
BioSynth Trust:发展对流式细胞仪基准合成数据集的理解和信心,以改善临床和细胞治疗诊断
  • 批准号:
    2796588
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship
Establishment of CAR-NK cell therapy using T/NK progenitor cells
利用T/NK祖细胞建立CAR-NK细胞疗法
  • 批准号:
    23K15308
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了